Israel Cannabis

Cannabinoid Leader Innocan Pharma's Q3: 174% YoY Revenue Growth
France's Cannabis Plans Face Delays, Israel's Secret Weed Lab And More Global Updates
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company
France's Cannabis Plans Face Delays, Israel's Secret Weed Lab And More Global Updates
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company
'The Whole World Is In Overdose,' Says CEO Of Company Behind Cannabis Inhaler That Enables Controlled Dosing
Promising Results In Medical Cannabis: CannaMore's Successful Phase 2a Trial For Colitis Treatment

Israel Cannabis Recent News

Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ
The potential rescheduling of cannabis in the U.S.
534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations
Innocan Pharma's 2023 earnings report: Revenue soars 534%, operating loss down 61%, $1.5M capital raise. CEO shares strategic vision.
IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial and operational results for the year ended Dec. 2023. The Toronto-headquartered medical cannabis company with a focus on Israel and Germany reported a 10% year-over-year decrease in revenue to CA$48.8 million ($36 million) in 2023. IM Cannabis attributed it to "negative currency fluctuations and the impact of the Israel-Hamas war on the company's operations." Fourth quarter revenue dropped 26% year-over-year to CA$10.7 million. "As previously warned and as expected, unfortunately, the Israel-Hamas war had a negative impact on our fourth quarter 2023 results, which weighed on our full-year results.," Uri Birenberg, chief financial officer of IMC, said. "Coupled with our fourth quarter of 2023 inventory reduction, the war caused our fourth quarter gross profit to decrease by 68% as compared to the fourth quarter of 2022."
Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
Evogene Ltd. released its fourth-quarter and full-year 2023 financial results, showing a 237% revenue increase for the year. Despite a 12% revenue decrease in Q4, the Israeli cannabis company reported $5.6 million in total revenue for the year. CEO Ofer Haviv highlighted the company's successful collaborations with industry leaders like Corteva, ICL, and Syngenta, contributing to revenue growth. In Q4, gross profit decreased to $180,000, but net financing income rose to $287,000. Total operating expenses increased to $7.8 million, leading to a net loss of $7.3 million. For the full year, gross profit reached $3.9 million, and net financing income was approximately $521,000. Evogene also secured partnerships with Verb Biotics and Colors Farm, along with receiving a €1.2 million EU grant for its Ag-Seed Division's research and development efforts.
Top Canadian Cannabis Producers Caught In International Controversy Over Imports
Israel's Trade Levies Unit launched an anti-dumping investigation into the import of medical cannabis from Canada, saying it causes injury to the domestic cannabis industry in Israel.
War In Gaza Forces Israel To Delay Medical Cannabis Reform
The Israel Ministry of Health announced the anticipated reform of medical cannabis regulations
Tilray CEO Irwin Simon Visits Israel To Meet Business Partners And Germany Ahead Of Imminent Legalization
Irwin Simon, a chairman and CEO of the largest Canadian cannabis company in the world, Tilray Brands (NASDAQ: TLRY), recently took a business and personal trip to Israel amid the war with Hamas and to Germany, as legal cannabis seems to be on the horizon.
Cannabis Market Evolves In Israel Amid War With Hamas, New Merger On The Horizon
Over the years, Israel has grown into an international giant in the cannabis industry.
Israeli Maker Of Toothpick-Sized Cannabis Products Debuts On CSE
StickIt Technologies Inc. (CSE: STKT), parent company of Israeli technology and cannabinoid company StickIt Ltd., the developer exclusivity and patent protected of "Cannabis Sticks" debuted on the Canadian Securities Exchange (CSE) on Friday.
Israeli Police Seize Record 137,000 Cannabis Plants In Largest Operation Ever
Announcing one of the largest cannabis seizures in Israeli history, police said they had seized 137,550 plants.
Israeli Cannabis Co. Reports Solid Q2 Performance, Nearing Growth Targets
Cannabis company Evogene Ltd.
These Companies Are Ready To Capitalize On Latest Marijuana Reforms In Israel And Germany
Cannabis companies in the U.S. and Canada are capitalizing on the expanding European market as attitudes toward cannabis products continue to evolve and regulatory frameworks become more favorable.
Medical Marijuana Covered For Victims Of Hostilities In Israel: Plus Pot News Around The World
Israel: NII To Fully Cover Medical Marijuana For Victims Of Hostilities
Ireland's First Cannabis Treatment Tracking App, Finlands Bans Cannabinoid, Sweden To Follow
Ireland's First Oleocare allows patients in Ireland who use medicinal cannabis to monitor their treatment in real-time.
Cannabis Goes Global: Here's What You Need To Know To Avoid A Bad Case Of FOMO
Cannabis legalization has been a major focus of debate in recent years in the U.S. Now the conversation is taking place on a global scale as more countries consider the potential benefits of the policy change.
'Hypocrite Oath': Group Of Doctors Illegally Selling Medical Marijuana Licenses In Israel Caught
A group of senior doctors selling medical marijuana licenses online in Israel was caught by the police on Monday, reported the Jerusalem Post. The Israeli police detained or arrested around 15 suspects, illegally working in 20 locations.
Israel Announces First Export Of Medical Cannabis Seeds To The US
The Agriculture Ministry of Israel announced late Wednesday that the first export of Israeli cannabis seeds to the U.S.
IM Cannabis To Buy Jerusalem-Based Medical Marijuana Pharmacy For $4.9M In Cash And Stock
IM Cannabis Corp. (CSE: IMCC), (NASDAQ: IMCC) will acquire the majority of Jerusalem’s leading medical cannabis pharmacy, Oranim. The cannabis company confirmed Wednesday that its Israeli subsidiary IMC Holdings Ltd.
IM Cannabis Doubles Down On Israeli Cannabis Market With Two Acquisitions For $3.7M
Multi-country operator IM Cannabis (CSE: IMCC) (NASDAQ: IMCC), one of Israel’s pioneering medical cannabis companies with operations in Canada and Germany, announced a string of acquisitions this week that further expand its footprint in the fast-growing Israeli medical cannabis
Cannabis Companies Aleafia, Charlotte's Web Plan To Enter Israeli Market
More and more cannabis companies recognize the huge potential of the Israeli market. It is said to be one of the fastest-growing medical cannabis markets in the world, already having more than 60,000 registered patients. It is also known that some of the first successful researches on cannabis have been conducted in this country.
Israeli Cannabis Co. Univo Will Enter The U.K. Market
Israeli medical cannabis company Univo Pharmaceuticals Ltd. (TLV: UNVO) has agreed to a U.K. distribution deal. As part of the agreement, Univo will see up to five tons of its cannabis-based products distributed across the U.K. each year.
'A True Breakthrough': BOL Pharma Completes Medical Cannabis Export From Israel To UK
Israel's Ministry Of Health Greenlights University Of Haifa PTSD, Cannabis Pre-Clinical Study
;

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved